Invention Application
- Patent Title: TUMOR THERAPEUTIC AGENT
-
Application No.: US15750712Application Date: 2016-08-18
-
Publication No.: US20190000797A1Publication Date: 2019-01-03
- Inventor: Kiyoshi Okamoto , Junji Matsui , Corina Dutcus
- Applicant: Eisai R&D Management Co., Ltd.
- Applicant Address: JP Tokyo
- Assignee: Eisai R&D Management Co., Ltd.
- Current Assignee: Eisai R&D Management Co., Ltd.
- Current Assignee Address: JP Tokyo
- International Application: PCT/JP2016/074090 WO 20160818
- Main IPC: A61K31/357
- IPC: A61K31/357 ; A61K31/47 ; A61P35/00 ; A61K31/664
Abstract:
A novel tumor therapeutic agent for a combination therapy is disclosed. More specifically, a tumor therapeutic agent used for a combination therapy of lenvatinib, ifosfamide, and etoposide is disclosed.
Public/Granted literature
- US12220398B2 Tumor therapeutic agent Public/Granted day:2025-02-11
Information query
